India’s Precision Medicine: A Vision Hindered by Biobank Regulations
Precision medicine, a transformative approach to healthcare, is redefining the landscape of disease diagnosis and treatment. From groundbreaking personalised healthcare solutions to innovations like mRNA vaccines and gene-editing technologies, the field promises a new era in medical science. Yet, as India stands on the cusp of this revolution, a significant hurdle looms: the lack of robust biobank regulations.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent analysis by The Hindu, India’s inconsistent biobank regulations threaten public trust and impede progress.
The Promise of Precision Medicine
In recent years, precision medicine has witnessed remarkable achievements. Through gene therapy, researchers have restored vision in individuals with genetic mutations, while in the U.K., scientists have reversed diabetes using reengineered stem cells. The rapid development of COVID-19 vaccines using the mRNA platform, which earned a Nobel Prize, further underscores the potential of precision medicine.
India’s Growing Market
The Indian precision medicine market is burgeoning, with projections estimating a value exceeding $5 billion by 2030. Initiatives like the BioE3 policy and the approval of NexCAR19, a domestically developed CAR-T cell therapy, mark significant strides. However, the true potential of these advancements lies in aligning biobank regulations with international standards.
The Biobank Conundrum
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the ICMR guidelines illustrate, participants often consent to provide samples without clarity on data usage, raising concerns about privacy and potential discrimination.
A Path Forward
To harness the full potential of precision medicine, India must establish stringent biobank regulations. Aligning with global standards will not only bolster public trust but also position India as a leader in next-generation therapeutics. As part of international groups like the Quad and BRICS, India has the opportunity to expand its pharmaceutical leadership and enhance its soft diplomatic efforts.
Manjeera Gowravaram, a PhD in RNA biochemistry, provides insightful analysis on the intersection of science and policy.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Florida’s property insurance system is once again spiraling as new “market-friendly” reforms fail to stabilize rising premiums, insurer failures, and mounting homeowner frustration. Despite aggressive efforts to shift policyholders from Citizens to private carriers, many of the new insurers stepping in are tied to past insolvencies, questionable ratings, and political influence. For real estate, mortgage, and insurance professionals, these systemic cracks are reshaping closings, valuations, and risk across the state—making it essential to stay ahead of ongoing regulatory and market shifts.
Commercial real estate is heading into a turning‑point year in 2026, driven by economic uncertainty, AI‑powered transformation, shifting demographics and rising portfolio risk. Insights from The Counselors of Real Estate highlight the top issues shaping the year ahead—from fiscal pressures and capital constraints to housing shortages, global volatility and the future of data‑driven decision‑making. For real estate, mortgage, insurance and finance professionals, these trends offer a clear roadmap for staying competitive and preparing for the next wave of industry change.
AI-powered tools, fraud protection systems, and smarter MLS integrations are sweeping through the real estate industry as major organizations adopt new technologies. From RealReports hitting its 50th partnership to BeachesMLS unveiling instant AI home visualizations and Doorify boosting security, professionals are seeing rapid advancements that promise sharper insights, safer transactions, and more efficient rental workflows. This evolving tech landscape underscores the importance of staying educated and adaptable — especially for agents preparing for a competitive, AI-enhanced 2025 market.
Florida homeowners are being hit with the highest insurance premiums in the nation, averaging $5,838 per year—nearly double the U.S. average. As costs skyrocket, many residents are reporting denied claims, non‑renewals, and impossible financial choices. New investigations reveal that more than 40 percent of claims in Florida close with no payment, while lawmakers push for transparency, fair pricing, and meaningful reform to stabilize a market that’s rapidly becoming unsustainable.
Vend Park, a Boston-based proptech company, has raised $17.5 million in Series A funding to reinvent parking as a high-performing commercial real estate asset. By replacing outdated operator–vendor systems with a unified AI-driven platform, Vend Park is helping major property owners boost NOI by up to 30%, slash operating costs, and modernize the tenant experience. As the company expands from three to fifteen cities and partners with giants like Nuveen and Jamestown, its technology highlights a major shift: real estate professionals must now understand AI, automation, and digital infrastructure to stay competitive.
Keller Williams Realty Atlanta Partners has formed an exclusive partnership with Southeast Mortgage, Georgia’s largest non‑bank mortgage lender. The collaboration promises faster, tech‑enhanced transactions for both agents and homebuyers, combining real estate expertise with streamlined mortgage services. This move reflects a growing trend toward integrated real‑estate ecosystems designed to reduce delays, boost transparency, and modernize the homebuying experience.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent 
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the 
